BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEB2024 Q2 Job Market Report: More People Competing for Fewer Job Openings. For the second quarter of 2024, there were 25% fewer jobs posted live on BioSpace compared to the same quarter of 2023. The year-over-year job response rate rose from 14.6% to …
Biopharma Mergers & Acquisitions - BioSpace
WEBLilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech. Eli Lilly is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right …
News - BioSpace
WEBBioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The latest biotech and pharmaceutical news from BioSpace.
Wet Lab vs Dry Lab: Challenges, Benefits and Skills Required
WEBJan 25, 2023 · In a wet lab, testing and analyses are performed using physical samples, chemicals and liquids. Biological samples, drugs and fluids are all tested in a wet lab. In other words, “wet” materials are tested. In a dry lab, testing and analyses is performed using data, coding and computer systems. Modeling and analysis normally take place in a ...
Q1 2021: A Look at Top 25 Biopharma Companies by Market Cap
WEBMay 2, 2021 · Pfizer expects to bring in $15 billion from the vaccine in 2021, which would greatly contribute to the $59 billion to $61 billion it expects to earn overall for the year. Abbott $213.19 billion. The pharma giant of the Midwest kicked off 2021 strong, announcing $10.5 billion in sales, a growth rate of 35.3 percent in Q1.
Roche’s Obesity Pill Candidate Hit With Safety Concerns
WEB5 days ago · Roche ’s investigational obesity pill CT-996 appears to have substantial safety concerns, according to data presented on Wednesday at the 2024 annual meeting of the European Association for the Study of Diabetes.. After four weeks, patients whose CT-996 doses were ramped up rapidly lost 7.3% of their body weight, while placebo comparators …
Phase III Clinical Trials - BioSpace
WEBSep 11, 2024 · AstraZeneca’s Imfinzi Fails Phase III NSCLC Trial, Aces Late-Stage Bladder Cancer Study. AstraZeneca’s PD-L1 inhibitor failed to significantly improve disease-free survival in patients with non-small cell lung cancer, but hit its primary endpoint in a late-stage trial in muscle-invasive bladder cancer. June 25, 2024.
FDA News: Approvals, Adcomms, Complete Response Letters and …
WEBJul 15, 2024 · Tristan Manalac. Approvals. Servier Gets FDA Approval for First Targeted Therapy for Grade 2 IDH-Mutant Glioma. Servier Pharmaceuticals’ vorasidenib on Tuesday secured the FDA’s green light for the treatment of patients with grade 2 gliomas carrying mutations in the IDH gene. August 7, 2024.
Biopharma Layoff Tracker 2024: Biosense Webster, Charles
WEB5 days ago · September 5. Shortly after an SEC filing reported the company’s financial challenges, ImmunityBio is laying off 16 employees in California (five in Culver City and 11 in El Segundo), according to an Aug. 30 Worker Adjustment and Retraining Notification Act notice.The biotech’s workforce reduction will be effective Oct. 29.. ImmunityBio is …
Cancer - BioSpace
WEBFDA Adcomm Calls for Changes in Perioperative Lung Cancer Trials. The FDA’s Oncologic Drugs Advisory Committee on Thursday strongly supported changing clinical trials for non-small cell lung cancer drugs given in the perioperative setting, pointing out the need for a more nuanced approached to treatments before and after surgery. July 26, 2024.
Skip to content